No Data
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $6
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH) and Maravai Lifesciences Holdings (MRVI)
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)
Guggenheim Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
Maravai LifeSciences | 10-Q: Q1 2026 Earnings Report
12 Health Care Stocks Moving In Friday's Intraday Session